PLOD2
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
Also known as: LH2, PLOD2_HUMAN, TLH
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00469
- Gene
- PLOD2
- Ensembl
- ENSG00000152952
- Chromosome
- 3
- Canonical length
- 737 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli,Cytosol
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a membrane-bound homodimeric enzyme that is localized to the cisternae of the rough endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VIB have deficiencies in lysyl hydroxylase activity. Mutations in the coding region of this gene are associated with Bruck syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
737 residues, UniProt reviewed canonical sequence.
>O00469|PLOD2
1 MGGCTVKPQL LLLALVLHPW NPCLGADSEK PSSIPTDKLL VITVATKESD GFHRFMQSAK
61 YFNYTVKVLG QGEEWRGGDG INSIGGGQKV RLMKEVMEHY ADQDDLVVMF TECFDVIFAG
121 GPEEVLKKFQ KANHKVVFAA DGILWPDKRL ADKYPVVHIG KRYLNSGGFI GYAPYVNRIV
181 QQWNLQDNDD DQLFYTKVYI DPLKREAINI TLDHKCKIFQ TLNGAVDEVV LKFENGKARA
241 KNTFYETLPV AINGNGPTKI LLNYFGNYVP NSWTQDNGCT LCEFDTVDLS AVDVHPNVSI
301 GVFIEQPTPF LPRFLDILLT LDYPKEALKL FIHNKEVYHE KDIKVFFDKA KHEIKTIKIV
361 GPEENLSQAE ARNMGMDFCR QDEKCDYYFS VDADVVLTNP RTLKILIEQN RKIIAPLVTR
421 HGKLWSNFWG ALSPDGYYAR SEDYVDIVQG NRVGVWNVPY MANVYLIKGK TLRSEMNERN
481 YFVRDKLDPD MALCRNAREM GVFMYISNRH EFGRLLSTAN YNTSHYNNDL WQIFENPVDW
541 KEKYINRDYS KIFTENIVEQ PCPDVFWFPI FSEKACDELV EEMEHYGKWS GGKHHDSRIS
601 GGYENVPTDD IHMKQVDLEN VWLHFIREFI APVTLKVFAG YYTKGFALLN FVVKYSPERQ
661 RSLRPHHDAS TFTINIALNN VGEDFQGGGC KFLRYNCSIE SPRKGWSFMH PGRLTHLHEG
721 LPVKNGTRYI AVSFIDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLOD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 76 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 76 nTPM
- placenta: 64 nTPM
- liver: 53 nTPM
- adipose tissue: 46 nTPM
- blood vessel: 38 nTPM
- duodenum: 37 nTPM
Single-cell type
- pancreatic acinar cells: 1,733 nCPM
- pancreatic islet cells: 415 nCPM
- epicardial cells: 330 nCPM
- smooth muscle cells: 324 nCPM
- extravillous trophoblasts: 306 nCPM
- adipocytes: 273 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- medulla oblongata: 17 nTPM
- choroid plexus: 15 nTPM
- thalamus: 12 nTPM
- white matter: 11 nTPM
- spinal cord: 11 nTPM
- midbrain: 10 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PLOD2.
Disease | AllUniProt
Conditions PLOD2 is implicated in, by any mechanism.
- Bruck syndrome 2 (BRKS2) MIM:609220
Disease | GeneticClinVar
39 pathogenic / likely-pathogenic of 547 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bruck syndrome 2
- Osteogenesis imperfecta
- 9 conditions
- PLOD2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- collagen biosynthetic process
- collagen fibril organization
- hydroxylysine biosynthetic process
- response to hypoxia
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Procollagen-lysine 5-dioxygenase, conserved site
- Oxoglutarate/iron-dependent dioxygenase domain
- Prolyl 4-hydroxylase, alpha subunit
- Nucleotide-diphospho-sugar transferases
- Isopenicillin N synthase-like, Fe(2+) 2OG dioxygenase domain
- Collagen-modifying Glycosyltransferase 25
- PLOD1-3-like, GT domain
- 2OG-Fe(II) oxygenase superfamily
- PLOD GT domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLOD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLOD2 as an antibody target. Whether an autoantibody or antibody against PLOD2 could matter depends on whether native PLOD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLOD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLOD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...